JOSEPH CECIL: Open Payments
NPI 1215646377 · BOWLING GREEN, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,211 in 108 payments from 15 companies in 2025. Trend: 2023 $2,038 · 2024 $2,421 · 2025 $2,211
Food & beverage: $2,132Education: $79
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 28 | $381 |
| UCB, Inc. | 17 | $326 |
| Janssen Biotech, Inc. | 14 | $298 |
| Galderma Laboratories, L.P. | 3 | $277 |
| Regeneron Healthcare Solutions, Inc. | 8 | $264 |
| E.R. Squibb & Sons, L.L.C. | 9 | $188 |
| Lilly USA, LLC | 6 | $111 |
| Amgen Inc. | 6 | $92 |
| LEO Pharma Inc. | 5 | $83 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $47 |
Products named: Bimzelx, TREMFYA, DUPIXENT, NEMLUVIO, SKYRIZI, Sotyktu, RINVOQ, OTEZLA.
Industry payments across KY — which companies pay providers there.
